Literature DB >> 23360805

Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats.

Andreas Heuer1, Mariah J Lelos, Claire M Kelly, Eduardo M Torres, Stephen B Dunnett.   

Abstract

Unilateral infusion of 6-hydroxydopamine into the nigro-striatal pathway in the rat is the most common dopamine lesion model of Parkinson's disease. In the present study, we explore the impact of near complete unilateral loss of dopamine along the nigro-striatal pathway and subsequent cell replacement therapy in a choice reaction time task in rats, with assessment of spatial responding towards either side of the body (ipsilateral or contralateral to the lesion) on alternate days. Results indicated a stable contralateral deficit in response accuracy, reaction times and motor function for 50 consecutive days of testing, with no signs of recovery or compensation. All lesioned rats developed a near-hole bias and displayed prolonged movement and reaction times when responses had to be directed towards a distal response location on the side of the body contralateral to the lesion, as well as a smaller ipsilateral impairment in response accuracy and movement times. Grafts of dopamine-rich tissue into the denervated striatum improved some, but not all, of the deficits induced by the lesion. Specifically, grafted rats performed at a similar level to control animals when assessed on the ipsilateral side, they demonstrated a partial restitution of their ability to respond to far contralateral stimuli, and they exhibited a marked reduction in the time to complete all lateralised responses on both sides. The present characterisation of the task and the effects of cell replacement via primary fetal mesencephalic tissue demonstrate restorative properties in alleviating the marked spatial response bias induced by unilateral loss of dopamine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-Hydroxydopamine; 9-Hole box; Choice reaction time; Egocentric; Graft; Operant behaviour; Parkinson's disease; Primary fetal tissue; Spatial; Striatum; Ventral mesencephalon

Mesh:

Substances:

Year:  2013        PMID: 23360805     DOI: 10.1016/j.expneurol.2013.01.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  Inverse Expression Levels of EphrinA3 and EphrinA5 Contribute to Dopaminergic Differentiation of Human SH-SY5Y Cells.

Authors:  Ting Wang; Jing Chen; Chuan-Xi Tang; Xiao-Yan Zhou; Dian-Shuai Gao
Journal:  J Mol Neurosci       Date:  2016-05-23       Impact factor: 3.444

2.  Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.

Authors:  M J Lelos; R J Morgan; C M Kelly; E M Torres; A E Rosser; S B Dunnett
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

3.  Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease.

Authors:  Ludivine S Breger; Korbinian Kienle; Gaynor A Smith; Stephen B Dunnett; Emma L Lane
Journal:  Brain Behav Immun       Date:  2016-11-15       Impact factor: 7.217

4.  A comparison of AAV-vector production methods for gene therapy and preclinical assessment.

Authors:  Marcus Davidsson; Matilde Negrini; Swantje Hauser; Alexander Svanbergsson; Marcus Lockowandt; Giuseppe Tomasello; Fredric P Manfredsson; Andreas Heuer
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

5.  A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants.

Authors:  Patrick Aldrin-Kirk; Malin Åkerblom; Tiago Cardoso; Sara Nolbrant; Andrew F Adler; Xiaohe Liu; Andreas Heuer; Marcus Davidsson; Malin Parmar; Tomas Björklund
Journal:  Stem Cell Reports       Date:  2021-12-30       Impact factor: 7.765

6.  Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.

Authors:  Matilde Negrini; Giuseppe Tomasello; Marcus Davidsson; Alexis Fenyi; Cécile Adant; Swantje Hauser; Elena Espa; Francesco Gubinelli; Fredric P Manfredsson; Ronald Melki; Andreas Heuer
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  Poly(ethylene glycol) based nanotubes for tuneable drug delivery to glioblastoma multiforme.

Authors:  Majed Alghamdi; Filippo Chierchini; Dimitri Eigel; Christian Taplan; Thomas Miles; Dagmar Pette; Petra B Welzel; Carsten Werner; Wenxin Wang; Catia Neto; Mark Gumbleton; Ben Newland
Journal:  Nanoscale Adv       Date:  2020-08-24

8.  Defining the unknowns for cell therapies in Parkinson's disease.

Authors:  Emma L Lane; Mariah J Lelos
Journal:  Dis Model Mech       Date:  2022-09-27       Impact factor: 5.732

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.